Important note
This AI stock analysis for Lifestance Health is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!
Lifestance Health - AI Stock Analysis
Analysis generated January 15, 2025
LifeStance Health (LFST) is a behavioral healthcare company that offers various mental health services. The company provides therapy and psychiatric care through in-person visits and telehealth options, aiming to ensure broader access to mental health care. The company’s mission is to increase access to mental healthcare services in communities across the United States.
Fundamental Analysis
Revenue for the last quarter was $313 million, marking an increase of 0.13% compared to the previous quarter. This slight uptick indicates a stable growth pattern. Significantly, compared to the same quarter last year, revenue is up by 18.95%, suggesting strong year-over-year growth and robust performance.
Net income for the last quarter stood at $6 million, reflecting an impressive increase of 74.41% compared to the previous quarter. When looking at the year-over-year change, net income increased by 90.33%, highlighting efficient cost management and improved profitability.
EBITDA for the last quarter was $15 million, which represents a staggering increase of 740.51% compared to the previous quarter. Moreover, compared to the same quarter last year, EBITDA is up by 128.65%. This indicates a significant enhancement in operational efficiency, further underpinning the company’s sound financial health.
Technical Analysis
Today’s stock price is $7.94, an increase of 10.74% compared to a month ago, indicating a favorable short-term trend. Compared to a year ago, there is an increase of 15.91%, suggesting a positive long-term trend. The overall trend appears bullish.
The current SMA10 is 7.72, slightly higher than the previous SMA10 of 7.71, indicating a potential upward trend in price movement. The Relative Strength Index (RSI) is currently 30.4, signifying a neutral condition. These indicators collectively suggest a modest, yet positive, upward momentum in the stock price.
Alternative Data Analysis
In terms of job postings and employee sentiment, LifeStance Health has 1,312 open positions, down by 5% in the past couple of months. This decline could indicate cost-cutting measures or efforts to improve profit margins, a potentially concerning sign for a growing company. The business outlook among employees remains neutral.
As for customer acquisition, the company boasts an estimated 2.1 million visitors to its webpage, up by 35% in the last couple of months. This significant increase in web traffic is a bullish indicator, suggesting a potential rise in customer base.
Regarding customer engagement, the company's Instagram page has 25,000 followers, up by 8% in the past couple of months, indicating increased interest. Moreover, the Twitter page has 570 followers, albeit down by 3% in recent months, suggesting a slight decline in interest.
Finally, AltIndex's AI score for LifeStance Health is 65, designating a buy signal based on a composite of fundamental, technical, and alternative data analysis.
Conclusion
Overall, LifeStance Health showcases several positive indicators across fundamental, technical, and alternative data analyses. The company has demonstrated steady revenue and income growth, significant improvements in EBITDA, and a bullish stock trend. While the slight decrease in job postings and Twitter followers could be areas of concern, the increase in website visitors and Instagram followers, combined with a favorable AI score, strengthen the investment case.
Based on all the data analyzed, the recommendation for LifeStance Health stock is a buy.
Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.
